Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v17-EN
Language English English
Date Updated 2023-04-28 2023-04-27
Drug Identification Number 02403196 02403196
Brand name ACT CLARITHROMYCIN XL ACT CLARITHROMYCIN XL
Common or Proper name CLARITHROMYC FC TABLETS 500MG CLARITHROMYC FC TABLETS 500MG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CLARITHROMYCIN CLARITHROMYCIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-08 2020-07-08
Estimated end date Unknown Unknown
Actual end date 2023-04-27 2023-04-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments